Skip to main content

Table 5 Bioelectrical impedance analysis results for non-COVID-19 outpatients with thyroid diseases

From: Nonthyroidal illness syndrome (NTIS) in severe COVID-19 patients: role of T3 on the Na/K pump gene expression and on hydroelectrolytic equilibrium

  Rz (W) Xc (W) TBW (%) ECW (%) ICW (%) Nae:Ke (ratio) PhA (°)
Non-COVID-19 outpatients with thyroid diseases (n. 96)
 Subclinical hyperthyroidism (n. 19) 561.5 ± 96.0 44.7 ± 9.8 52.2 ± 6.7 53.8 ± 7.7 46.2 ± 7.7 1.3 ± 0.3 4.7 ± 1.1
 Euthyroidism (n. 57) 540.3 ± 78.3 49.0 ± 17.1 51.2 ± 6.7 50.9 ± 6.1 49.1 ± 6.1 1.1 ± 0.2 5.1 ± 1.2
 Subclinical hypothyroidism (n. 12) 552.3 ± 104.6 49.6 ± 16.0 55.0 ± 7.0 50.9 ± 4.7 49.1 ± 4.7 1.2 ± 0.3 5.1 ± 0.8
 Overt hypothyroidism (n. 7) 522.6 ± 87.8 47.7 ± 10.4 52.2 ± 8.3 49.9 ± 7.0 50.7 ± 7.0 1.2 ± 0.3 5.3 ± 1.3
 Myxedema (n. 1) 459 29 57.2 60.2 39.8 1.57 3.6